Register for Digital Look

Company Announcements

Loan Facility

Related Companies

RNS Number : 8896Q
Origo Partners PLC
05 December 2016
 

5 December 2016

Origo Partners plc

("Origo" or the "Company")

 

Loan Facility

 

Origo is a closed-end investment company which holds a portfolio of investments in unquoted, and illiquid, publicly traded companies based or principally active in China and Mongolia. Origo is seeking, through an orderly realisation programme, to divest its entire portfolio by November 2018.

 

The Company announces that it has entered into an unsecured loan agreement with Lars Bader (the "Lender") under which the Lender has provided the Company with a US$2.5 million (approximately £2 million) unsecured loan (the "Facility"). The Facility carries a rate of return (payable at repayment) of the higher of 12% per annum (calculated on a non-compounding basis) and 1.5 times the amount of the Facility.

 

The Facility is repayable on the earlier of (i) 2 December 2020; and (ii) when the Company has distributed US$6 million to the Company's shareholders in accordance with articles 4.10 to 4.12 of the Company's articles of association ("Articles") provided it has sufficient funds to repay the Facility. The Company may at any time prepay the Facility, in whole or in part, without penalty.  The proceeds of the Facility will be applied, in accordance with article 13.1.1 of the Articles, to discharging Origo liabilities to professional advisors (excluding those of Origo Advisors Limited) existing as at 19 August 2016.  

 

 

For further information about Origo please visit www.origoplc.com or contact: 

 

Origo Partners plc

Niklas Ponnert

 

  niklas@origoplc.com 

 

Nominated Adviser  and Broker

Smith & Williamson Corporate Finance Limited

Azhic Basirov

Ben Jeynes 

 

+44 (0)20 7131 4000

 

Public Relations

Aura Financial

Andy Mills 

 

 

+44 (0)20 7321 0000

 

 

Special note concerning the Market Abuse Regulation

 

Certain of the information contained in this announcement is deemed to constitute inside information for the purposes of article 7 of Regulation (EU) 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSOWRNUAURAA

Top of Page